EXOZYMES INC (EXOZ:NASDAQ)
$10.48 -0.18 (-1.6886%)
Analysed EXOZYMES INC (EXOZ:NASDAQ) News Sources
eXoZymes CCO, Damien Perriman, Outlines NCTx Strategy and the Commercial Path for Cell-Free Biomanufacturing on Grow Everything Podcast
10-04-2026
yahoo.com
MDB Capital Holdings LLC (MDBH) Q4 2025 Earnings Call Highlights: Strategic Innovations and ...
07-04-2026
yahoo.com
EXoZymes Inc (EXOZ) Q4 2025 Earnings Call Highlights: Strategic Advances Amid Financial Challenges
01-04-2026
yahoo.com
eXoZymes Q4 Earnings Call Highlights
31-03-2026
marketbeat.com
eXoZymes Provides Fourth Quarter and Full Year 2025 Update
31-03-2026
yahoo.com
MDB Capital Holdings Provides 2025 Full Year Update and Shareholder Letter
31-03-2026
yahoo.com
eXoZymes to Host Fourth Quarter and Full Year 2025 Results Conference Call on Tuesday March 31, 2026
25-03-2026
yahoo.com
Successful Pilot Scale Run with Cayman Chemical Validates eXoZymes' Technology and Scalability
18-03-2026
yahoo.com
eXoZymes' CCO Damien Perriman to Present a NCT Solution at Next Week's MISTA Symposium
12-03-2026
yahoo.com
With Refreshed Brand eXoZymes Sharpens Pharmaceutical Focus to Drive Platform Leverage and Long-Term Value Creation
10-02-2026
yahoo.com
What is the current price of EXOZYMES INC (EXOZ:NASDAQ)?
The current price of EXOZYMES INC (EXOZ:NASDAQ) is $10.48.
EXOZYMES INC (EXOZ:NASDAQ) absolute price change since previous trading day?
The absolute price change of EXOZYMES INC (EXOZ:NASDAQ) since the previous trading day is $-0.18.
EXOZYMES INC (EXOZ:NASDAQ) percentage price change since previous trading day?
The percentage price change of EXOZYMES INC (EXOZ:NASDAQ) since the previous trading day is -1.6886%.
What is the most recent average sentiment score for EXOZYMES INC (EXOZ:NASDAQ)?
The most recent average sentiment score for EXOZYMES INC (EXOZ:NASDAQ) is 89 out of 100.
What is the most recent average sentiment for EXOZYMES INC (EXOZ:NASDAQ)?
The most recent sentiment for EXOZYMES INC (EXOZ:NASDAQ) is .
SEC-8K** Filing Available For EXOZYMES INC (EXOZ:NASDAQ)
** material developments that could impact a company's financial condition or stock price.
Author: MattELab
MattELab is the founder and lead developer of SentientMerchant. With a Computer Science and Quantitative Finance background from a T10 university, he brings over 6 years of expertise in NLP, programmatic SEO, and full-stack development to build highly scalable AI and FinTech solutions.